D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.7B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$880M |
| 3 |
Boeing
BA
|
+$850M |
| 4 |
Eli Lilly
LLY
|
+$689M |
| 5 |
Tesla
TSLA
|
+$665M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$964M |
| 2 |
Apple
AAPL
|
+$606M |
| 3 |
Workday
WDAY
|
+$520M |
| 4 |
Palantir
PLTR
|
+$514M |
| 5 |
Spotify
SPOT
|
+$431M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.54% |
| 2 | Consumer Discretionary | 8.87% |
| 3 | Healthcare | 8.21% |
| 4 | Financials | 5.68% |
| 5 | Industrials | 4.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PLYA
1901
DELISTED
Playa Hotels & Resorts
PLYA
| $4.7M | ﹤0.01% |
371,399
-188,110
| -34% | -$1.78M |
|
1902
PUT
PennyMac Financial
PFSI
$4.47B
| $4.69M | ﹤0.01% |
45,900
+2,700
| +6% | +$282K |
|
1903
CALL
Magna International
MGA
$18.8B
| $4.68M | ﹤0.01% |
112,100
| – | – |
|
1904
PUT
Thermo Fisher Scientific
TMO
$214B
| $4.68M | ﹤0.01% |
+9,000
| New | +$4.95M |
|
1905
CALL
Aptiv
APTV
$12.3B
| $4.68M | ﹤0.01% |
77,300
+18,500
| +31% | +$1.13M |
|
|
BNY
1906
PUT
Bank of New York Mellon
BNY
$103B
| $4.67M | ﹤0.01% |
+60,800
| New | +$4.7M |
|
1907
Illumina
ILMN
$29.5B
| $4.67M | ﹤0.01% |
34,936
+1,800
| +5% | +$256K |
|
1908
Option Care Health
OPCH
$3.58B
| $4.66M | ﹤0.01% |
+200,751
| New | +$5.07M |
|
1909
Goldman Sachs
GS
$289B
| $4.66M | ﹤0.01% |
8,130
-44,069
| -84% | -$24.6M |
|
1910
PUT
Blue Owl Capital
OWL
$6.45B
| $4.65M | ﹤0.01% |
+200,000
| New | +$4.58M |
|
|
PCH
1911
DELISTED
PotlatchDeltic
PCH
| $4.65M | ﹤0.01% |
118,514
+35,664
| +43% | +$1.51M |
|
1912
IDEAYA Biosciences
IDYA
$3.43B
| $4.64M | ﹤0.01% |
180,676
-387,055
| -68% | -$11M |
|
|
BSII
1913
DELISTED
Black Spade Acquisition II Co Class A Ordinary Share
BSII
| $4.63M | ﹤0.01% |
+465,821
| New | +$4.61M |
|
1914
Xeris Biopharma Holdings
XERS
$1.45B
| $4.62M | ﹤0.01% |
1,363,452
+378,437
| +38% | +$1.22M |
|
1915
TETRA Technologies
TTI
$1.08B
| $4.62M | ﹤0.01% |
1,289,946
+403,086
| +45% | +$1.43M |
|
1916
STAG Industrial
STAG
$7.5B
| $4.61M | ﹤0.01% |
136,412
+123,129
| +927% | +$4.51M |
|
1917
CALL
GigaCloud Technology
GCT
$1.55B
| $4.61M | ﹤0.01% |
248,900
+179,200
| +257% | +$4.15M |
|
|
CVGW
1918
DELISTED
Calavo Growers
CVGW
| $4.6M | ﹤0.01% |
180,268
+57,575
| +47% | +$1.57M |
|
1919
PUT
Valaris
VAL
$5.14B
| $4.6M | ﹤0.01% |
103,900
+81,300
| +360% | +$3.91M |
|
1920
American Vanguard Corp
AVD
$68.7M
| $4.58M | ﹤0.01% |
990,238
+88,070
| +10% | +$477K |
|
1921
CALL
Alaska Air
ALK
$5.11B
| $4.58M | ﹤0.01% |
70,800
| – | – |
|
1922
Packaging Corp of America
PKG
$22.2B
| $4.58M | ﹤0.01% |
20,339
-6,352
| -24% | -$1.47M |
|
1923
Parker-Hannifin
PH
$120B
| $4.58M | ﹤0.01% |
7,199
-18,810
| -72% | -$12.5M |
|
1924
Laureate Education
LAUR
$5.38B
| $4.58M | ﹤0.01% |
250,336
+197,964
| +378% | +$3.47M |
|
1925
Essex Property Trust
ESS
$19.1B
| $4.58M | ﹤0.01% |
16,033
+10,510
| +190% | +$3.11M |
|
Similar funds
D.E. Shaw & Co's Q4 2024 Portfolio in Review
As of Q4 2024, D.E. Shaw & Co held 5,079 positions worth $136B, up 17% from $116B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
D.E. Shaw & Co deployed $10.6B of net new capital in Q4 2024, opening 591 new positions and adding to 1,620 existing holdings. Its largest new stake was Lam Research: 3,525,438 shares worth $255M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was NVIDIA, an estimated $964M trimmed.
- D.E. Shaw & Co's largest Q4 2024 buy was Lam Research: 3,525,438 shares worth $255M.
- D.E. Shaw & Co added most to State Street SPDR S&P 500 ETF Trust in Q4 2024, an estimated $3.7B increase.
- D.E. Shaw & Co's biggest Q4 2024 reduction was NVIDIA, cutting an estimated $964M.
- D.E. Shaw & Co fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $81.4M.
- D.E. Shaw & Co's ten largest holdings make up 11% of its $136B portfolio in Q4 2024.
- D.E. Shaw & Co opened 591 new positions and closed 731 in Q4 2024.
- D.E. Shaw & Co's portfolio value rose 17% quarter-over-quarter to $136B.
Based on D.E. Shaw & Co's 13F filing for Q4 2024, filed 14 Feb 2025.